Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia

Disease Markers

Volumn 29, Issue 1, 2010, Pages 1-9

  Mailaparambil, Beena ^a   Krueger, Marcus ^a   Heizmann, Ulrike ^a   Schlegel, Katharina ^a   Heinze, Jessica ^a   Heinzmann, Andrea ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Association; bronchopulmonary dysplasia; genetic; polymorphism

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 8; LYMPHOTOXIN; TOLL LIKE RECEPTOR 10; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; BIRTH WEIGHT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GERMANY; GESTATIONAL AGE; HAPLOTYPE; HUMAN; INFANT; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77957236640     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0720     Document Type: Article

References (43)

1. M.C. Walsh, S. Szefler, J. Davis, M. Allen, L. Van Marter, S. Abman, L. Blackmon and A. Jobe, Summary proceedings from the bronchopulmonary dysplasia group, Pediatrics 117 (2006), 52-56. (Pubitemid 46063173)
2. J.P. Kinsella, A. Greenough and S.H. Abman, Bronchopulmonary dysplasia, Lancet 367 (2006), 1421-1431.
3. G. Bokodi, A. Treszl, L. Kovács, T. Tulassay, B. Vásárhelyi, Dysplasia, a review, Pediatr Pulmonol 42 (2007), 952-961.
4. W.H. Jr. Northway, R.C. Rosan and D.Y. Porter, Pulmonary disease following respirator therapy of hyalinemembrane disease. Bronchopulmonary dysplasia, N Engl JMed 276 (1967), 357-368.
5. Report of workshop on Bronchopulmonary dysplasia; NIH publication No. 80-1660.Washington, DC, National Institutes of Health; 1979.
6. A.H. Jobe, E. Bancalari, Bronchopulmonary displasia, Am J Respir Crit Care Med 163 (2001), 1723-1729.
7. R.A. Ehrenkranz, M.C. Walsh, B.R. Vohr, A.H. Jobe, L.L. Wright, A.A. Fanaroff, L.A. Wrage and K. Poole, National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia, Pediatrics 116 (2005), 1353-1360. (Pubitemid 46056482)
8. R.M. Ryan, A new look at bronchopulmonary dysplasia classification, J Perinatol 26 (2006), 207-209.
9. C.T. D'Angio and W.M. Maniscalco, The role of vascular growth factors in hyperoxiainduced injury to the developing lung, Front Biosci 7 (2002), 1609-1623.
10. F. Groenman, S. Unger and M. Post, The molecular basis for abnormal human lung development, Biol Neonate 87 (2005), 164-177. (Pubitemid 40591439)
11. R.M. Ryan, Q. Ahmed and S. Lakshminrusimha, Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia, Clin Rev Allergy Immunol 34 (2008), 174-190.
12. L.A. Parton, S.S. Strassberg, D. Qian, P.A. GalvinParton and I.A. Cristea, The genetic basis for bronchopulmonary dysplasia, Front Biosci 11 (2006), 1854-1860. (Pubitemid 43253398)
13. V. Bhandari, M.J. Bizzarro, A. Shetty, X. Zhong, G.P. Page, H. Zhang, L.R. Ment and J.R. Gruen, Neonatal Genetics Study Group.Familial and genetic susceptibility to major neonatal morbidities in preterm twins, Pediatrics 117 (2006), 1901-1906.
14. V. Bhandari and J.R. Gruen, The genetics of bronchopulmonary dysplasia, Semin Perinatol 30 (2006), 185-191. (Pubitemid 44062676)
15. A.Hadchouel, F.Decobert,M.L. FrancoMontoya, I.Halphen, P.H. Jarreau, O. Boucherat, E. Martin, A. Benachi, S. Amselem, J. Bourbon, C. Danan and C. Delacourt, Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development PLoS One 3 (2008), e3188.
16. B. Puthothu, M. Krueger, M. Bernhardt and A. Heinzmann, ICAM1 aminoacid variant K469E is associated with paediatric bronchial asthma and elevated sICAM1 levels, Genes Immun 7 (2006), 322-326. (Pubitemid 43871533)
17. M. Krueger, A. Heinzmann and M. Nauck, Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome, Intensive Care Med 33 (2007), 359-363. (Pubitemid 46221246)
18. C. Pieh,M. Krueger,W.A. Lagreze, C. Gimpel, C. Buschbeck, U. Zirrgiebel and H. Agostini, Plasma sEselectin in premature infants: A possible surrogate marker of retinopathy of prematurity, Invest Ophthalmol Vis Sci, (2010) Feb 24. [Epub ahead of print] PubMed PMID: 20181841.
19. A. Heinzmann, B. Mailaparambil, N. Mingurilli and M. Krueger, Association of Interleukin13/ 4 and Toll like receptor 10 with preterm births, Neonatology 96 (2009), 175-181.
20. P.M. Lavoie, C. Pham and K.L. Jang, Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health, Pediatrics 122 (2008), 479-485.
21. F. Sanger, S.Nicklen andA.R. Coulson, DNAsequencingwith chainterminating inhibitors 1977, Biotechnology 24 (1992), 104-108.
22. P.D. Sasieni, From genotypes to genes, doubling the sample size, Biometrics 53 (1997), 1253-1261.
23. J. Xu, A. Turner, J. Little, E.R. Bleecker and D.A. Meyers, Positive results in association studies are associated with departure from HardyWeinberg equilibrium, hint for genotyping error? Hum Genet 111 (2002), 573-574. (Pubitemid 36075091)
24. T. Becker and M. Knapp, Maximumlikelihood estimation of haplotype frequencies in nuclear families, Genet Epidemiol 27 (2004), 21-32. (Pubitemid 38808342)
25. E. Bancalari, Changes in the pathogenesis and prevention of chronic lung disease of prematurity, Am J Perinatol 18 (2001), 1-9. (Pubitemid 32245009)
26. M.A. Rojas, A. Gonzalez, E. Bancalari, N. Claure, C. Poole and G. SilvaNeto, Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease, J Pediatr 126 (1995), 605-610.
27. M. Palta, D. Gabbert, M.R. Weinstein and M.E. Peters, Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. The Newborn Lung Project, J Pediatr 119 (1991), 285-292.
28. M.H. Manar, M.R. Brown, T.W. Gauthier and L.A. Brown, Association of glutathioneStransferaseP1 (GSTP1) polymorphisms with bronchopulmonary dysplasia, J Perinatol 24 (2004), 30-35. (Pubitemid 38159800)
29. S.N.Kazzi, U.O.Kim,M.W.Quasney and I. Buhimschi, Polymorphism of tumor necrosis factoralpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants, Pediatrics 114 (2004), 243-248.
30. S.S. Strassberg, I.A. Cristea, D. Qian and L.A. Parton, Single nucleotide polymorphisms of tumor necrosis factoralpha and the susceptibility to bronchopulmonary dysplasia, Pediatr Pulmonol 42 (2007), 29-36. (Pubitemid 46080150)
31. S.N. Kazzi, G. Tromp, M.W. Quasney and I.A. Buhimschi, Haplotypes of tumor necrosis factor gene and tracheal aspirate fluid levels of tumor necrosis factoralpha in preterm infants, Pediatr Res 64 (2008), 165-170.
32. T. Higuchi, N. Seki, S. Kamizono, A. Yamada, A. Kimura, H. Kato and K. Itoh, Polymorphism of the 5'flanking region of the human tumor necrosis factor (TNF)alpha gene in Japanese, Tissue Antigens 51 (1998), 605-612. (Pubitemid 28306464)
33. B. Puthothu, S. Bierbaum, M.V. Kopp, J. Forster, J. Heinze, M. Weckmann, M. Krueger and A. Heinzmann, Association of TNFalpha with severe respiratory syncytial virus infection and bronchial asthma, Pediatr Allergy Immunol 20 (2009), 157-163.
34. M. Chauhan, S. Bombell and W. McGuire, Tumour necrosis factor (308A) polymorphism in very preterm infants with bronchopulmonary dysplasia, metaanalysis, Arch Dis Child Fetal Neonatal Ed 94 (2009), 257-259.
35. B. Thábaud, Angiogenesis in lung development, injury and repair, implications for chronic lung disease of prematurity, Neonatology 91 (2007), 291-297. (Pubitemid 46934214)
36. T.M.Asikainen, N.S.Waleh, B.K. Schneider, R.I. Clyman and C.W. White, Enhancement of angiogenic effectors through hypoxiainducible factor in preterm primate lung in vivo, Am J Physiol Lung Cell Mol Physiol 291 (2006), 588-595.
37. P. Lassus, A. Ristimäki, O. Ylikorkala, L. Viinikka, S. Andersson, Vascular endothelial growth factor in human preterm lung, Am J Respir Crit Care Med 159 (1999), 1429-1433. (Pubitemid 29227849)
38. C.J. Watson, N.J. Webb, M.J. Bottomley and P.E. Brenchley, Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene, correlation with variation in VEGF protein production, Cytokine 12 (2002), 1232-1235.
39. A. Stevens, J. Soden, P.E. Brenchley, S. Ralph, D.W. Ray, Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter, Cancer Res 63 (2003), 812-816. (Pubitemid 36231981)
40. P. Kwinta, M. BikMultanowski, Z. Mitkowska, T. Tomasik, M. Legutko and J.J. Pietrzyk, Genetic risk factors of bronchopulmonary dysplasia, Pediatr Res 64 (2008), 682-688.
41. R. Lazarus, B.A. Raby, C. Lange, E.K. Silverman, D.J. Kwiatkowski, D. Vercelli, W.J. Klimecki, F.D. Martinez and S.T. Weiss, TOLLlike receptor 10 genetic variation is associated with asthma in two independent samples, Am J Respir Crit Care Med 170 (2004), 594-600. (Pubitemid 39202199)
42. H.C. Lin, B.H. Su, J.S. Chang, C.M. Hsu, C.H. Tsai and F.J. Tsai, No association of interleukin 4 intron 3 and 590 promoter polymorphisms with bronchopulmonary dysplasia for ventilated preterm infants, Biol Neonate 87 (2005), 181-186.
43. J. Pavlovic, C. Papagaroufalis, M. Xanthou,W. Liu, R. Fan, N. J. Thomas, I. Apostolidou, E. Papathoma, E.Megaloyianni, S. DiAngelo and J. Floros, Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia, Dis Markers 22 (2006), 277-291. (Pubitemid 46333635)